Adal, Entisar T.
HRN: 13-59-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/24/2023
CEFAZOLIN 1GM (VIAL)
03/25/2023
03/25/2023
IV
1.5g
On Call To OR ANST
Prophylaxis For D&C
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes